Brazil pharmaceutical regulation

Latest Post

FDA Hosts Webinar on ICH M15 Guidance for Model-Informed Drug Development Baby Memorial Hospital Group Partners With DeepInfinity.AI to Scale Clinical AI Molecular Partners Plans 44% Workforce Reduction to Focus on Radiotherapeutics Geron Discontinues Phase III Myelofibrosis Trial After Survival Goal Setback Biogen Q3 2026 Results: Revenue Rises 11% as Company Raises Earnings Guidance

Indoco Remedies’ AnaCipher Wins ANVISA Approval in Brazil

October 28, 2026 Simone Lamb

The Indoco Remedies AnaCipher ANVISA approval lets the Hyderabad CRO run bioequivalence studies for Brazil. What it covers and what is undisclosed.

You missed

FDA Hosts Webinar on ICH M15 Guidance for Model-Informed Drug Development

October 30, 2026 Simone Lamb

Baby Memorial Hospital Group Partners With DeepInfinity.AI to Scale Clinical AI

October 30, 2026 Simone Lamb

Molecular Partners Plans 44% Workforce Reduction to Focus on Radiotherapeutics

October 30, 2026 Simone Lamb

Geron Discontinues Phase III Myelofibrosis Trial After Survival Goal Setback

October 30, 2026 Simone Lamb